Skip to main content
. 2016 Jun 11;7(31):49470–49480. doi: 10.18632/oncotarget.9943

Table 2. All primers used in this study.

Name Primer Sequence
U6 F 5′-CTCGCTTCGGCAGCACA-3′
U6 R 5′-AACGCTTCACGAATTTGCGT-3′
β-actin F 5′-CGTCTTCCCCTCCATCG-3′
β-actin R 5′-CTCGTTAATGTCACGCAC-3′
VDAC1 F 5′-ACGTATGCCGATCTTGGCAAA-3′
VDAC1 R 5′-TCAGGCCGTACTCAGTCCATC-3′
miR-320a F 5′-AAAAGCTGGGTTGAGAGGGCGA-3′
miR-320b F 5′-AAAAGCTGGGTTGAGAGGGCAA-3′
miR-320c F 5′-AAAAGCTGGGTTGAGAGGGT-3′
miR-320d F 5′-AAAAGCTGGGTTGAGAGGA-3′
VDAC1 (WT) F 5′-AAACTAGTTAGTGTATCTTTTAATGTTGTATGTCTGG-3′
VDAC1 (WT) R 5′-GGAAGCTTGGGTAACATCTTAAAGCTGAATCAAC-3′
VDAC1 (MUT) F 5′-AAACTAGTTAGTGTATCTTTTAATGTTGTATGTCTGG-3′
VDAC1 (MUT) R 5′-GGAAGCTTGGGTAACATCTTTTTCGACAATCAAC −3′
VDAC1 (pGL3) F 5′-AAAGGTACCATGGCTGTGCCACCCACGTATG-3′
VDAC1 (pGL3) R 5′-AAACTCGAGTTATGCTTGAAATTCCAGTCCTAG-3′

Abbreviations: F, forward primer; R, reverse primer; WT, wild type; MUT, mutant.